MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species.

Transl Res · 2018 · PMC7787305 · PMID 30053382

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In accordance with our “in house” results, we observed a significant relationship between the expression of MAFG and survival in our additional large cohort of 1035 patients analyzed from Moffitt Center and in the public database with 984 from TCGA with a clear trend toward higher overall survival when MAFG expression is low.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.